Clinical Trial Detail
| NCT ID | NCT02334527 |
| Title | Phase II Trial of Palbociclib (PD-0332991) in Patients With Metastatic Urothelial Cancer (UC) After Failure of First-Line Chemotherapy |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | UNC Lineberger Comprehensive Cancer Center |
| Indications |
urethra transitional cell carcinoma |
| Therapies | |
| Age Groups: | adult |
CKB BOOST